Gastric protective effect of peripheral PYY through PYY preferring receptors in anesthetized rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 283, Issue 5 46-5, 2002, Pages

  Kawakubo, Keishi ^a   Yang, Hong ^a   Taché, Yvette ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Ethanol; Gastric lesions; Neuropeptide Y receptor subtype; Peptide YY antibody; Vagotomy

Indexed keywords

ALCOHOL; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; RECEPTOR SUBTYPE; URETHAN;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STOMACH DISEASE; STOMACH EMPTYING; STOMACH MUCOSA; VAGOTOMY;

EID: 0036840622     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00154.2002     Document Type: Article

References (46)

1. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, and Bloom SR. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89: 494-499, 1985.
2. Al-Saffar A, Hellstrom PM, and Nylander G. Correlation between peptide YY-induced myoelectric activity and transit of small-intestinal contents in rats. Scand J Gastroenterol 20: 577-582, 1985.
3. Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, and Bloom SR. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30: 255-262, 1984.
4. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, and Rozé C. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflügers Arch 438: 299-306, 1999.
5. Balasubramaniam AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18: 445-457, 1997.
6. Bilchik AJ, Hines OJ, Ashley SW, Adrian TE, Walsh J, Wong H, Liu CD, Zinner MJ, and McFadden DW. Peptide YY immunoneutralization inhibits meal-induced absorption in vivo. Surgery 116: 1153-1157, 1994.
7. Bottcher G, Ekblad E, Ekman R, Hakanson R, and Sundler F. Peptide YY: a neuropeptide in the gut. Immunocytochemical and immunochemical evidence. Neuroscience 55: 281-290, 1993.
8. Chen CH, Stephens RLJ, and Rogers RC. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Motil 9: 109-116, 1997.
9. Diel F and Szabo S. Dose-dependent effects of linear and cyclic somatostatin on ethanol-induced gastric erosions: the role of mast cells and increased vascular permeability in the rat. Regul Pept 13: 235-243, 1986.
10. Eissele R, Koop H, and Arnold R. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat. Z Gastroenterol 28: 129-131, 1990.
11. Fu-Cheng X, Anini Y, Chariot J, Castex N, Galmiche JP, and Rozé C. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflügers Arch 433: 571-579, 1997.
12. Fung LC, Chisholm C, and Greenberg GR. Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs. Endocrinology 139: 189-194, 1998.
13. Greeley GHJ, Guo YS, Gomez G, Lluis F, Singh P, and Thompson JC. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat. Proc Soc Exp Biol Med 189: 325-328, 1988.
14. Gross PM, Wall KM, Pang JJ, Shaver SW, and Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol Regulatory Integrative Comp Physiol 259: R1131-R1138, 1990.
15. Gué M, Junien JL, Reeve JRJ, Rivier J, Grandt D, and Taché Y. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Br J Pharmacol 118: 237-242, 1996.
16. Guo YS, Fujimura M, Lluis F, Tsong Y, Greeley GH, and Thompson JC. Inhibitory action of peptide YY on gastric acid secretion. Am J Physiol Gastrointest Liver Physiol 253: G298-G302, 1987.
17. Guo YS, Singh P, Gomez G, Greeley GHJ, and Thompson JC. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones. Gastroenterology 92: 1202-1208, 1987.
18. Hernandez EJ, Whitcomb DC, Vigna SR, and Taylor IL. Saturable binding of circulating peptide YY in the dorsal vagal complex of rats. Am J Physiol Gastrointest Liver Physiol 266: G511-G516, 1994.
19. Jin H, Cai L, Lee K, Chang TM, Li P, Wagner D, and Chey WY. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 105: 208-215, 1993.
20. Kawakubo K, Yang H, and Taché Y. Intracisternal PYY inhibits gastric lesions induced by ethanol in rats: role of PYY-preferring receptors? Brain Res 854: 30-34, 2000.
21. Konturek SJ, Brzozowski T, Bielanski W, and Schally AV. Role of endogenous gastrin in gastroprotection. Eur J Pharmacol 278: 203-212, 1995.
22. Lin HC, Zhao XT, Wang L, and Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110: 1491-1495, 1996.
23. Lloyd KC, Grandt D, Aurang K, Eysselein VE, Schimiczek M, and Reeve JRJ. Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol Gastrointest Liver Physiol 270: G123-G127, 1996.
24. Lundberg JM, Tatemoto K, Terenius L, Hellstrom PM, Mutt V, Hokfelt T, and Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79: 4471-4475, 1982.
25. 125I-neuropeptide Y imply receptor heterogeneity. J Neurosci 9: 2607-2619, 1989.
26. Miyachi Y, Jitsuishi W, Miyoshi A, Fujita S, Mizuchi A, and Tatemoto K. The distribution of polypeptide YY-like immunoreactivity in rat tissues. Endocrinology 118: 2163-2167, 1986.
27. Nata K, Yonekura H, Yamamoto H, and Okamoto H. Identification of a novel 65-kDa cell surface receptor common to pancreatic polypeptide, neuropeptide Y and peptide YY. Biochem Biophys Res Commun 171: 330-335, 1990.
28. Olsen O and Christiansen J. Inhibition of human gastric acid secretion by peptide YY and secretin. Digestion 47: 156-159, 1990.
29. Pappas TN, Debas HT, Chang AM, and Taylor IL. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology 91: 1386-1389, 1986.
30. Pappas TN, Debas HT, and Taylor IL. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J Clin Invest 77:49-53, 1986.
31. Putnam WS, Liddle RA, and Williams JA. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol 256: G698-G703, 1989.
32. Raybould HE, Tabrizi Y, Meyer JH, and Walsh JH. PYY immunoneutralization does not alter lipid-induced inhibition of gastric emptying in rats. Regul Pept 79: 125-130, 1999.
33. Robert A, Nezamis JE, Lancaster C, and Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77: 433-443, 1979.
34. Souli A, Fu-Cheng X, Chariot J, Tsocas A, and Rozé C. Antisecretory effects of YY peptide and neuropeptide Y at three levels of the small intestine in rats. Effets antisecretoires du peptide YY et du neuropeptide Y a trois niveaux de l'intestin grele chez le rat. Gastroenterol Clin Biol 20: 8-14, 1996.
35. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79: 2514-2518, 1982.
36. Taylor IL. Role of peptide YY in the endocrine control of digestion. J Dairy Sci 76: 2094-2101, 1993.
37. Teyssen S, Grandt D, Niebergall-Roth E, Schimiczek M, Goebell H, Eysselein VE, Reeve JRJ, and Singer MV. Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors. Pancreas 13: 80-88, 1996.
38. Turnbull AV and Rivier CL. Intracerebroventricular passive immunization. II. Intracerebroventricular infusion of neuropeptide antisera can inhibit neuropeptide signaling in peripheral tissues. Endocrinology 139: 128-136, 1998.
39. Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, and Holst JJ. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29: 501-505, 1994.
40. Yang H. Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23: 349-358, 2002.
41. Yang H, Kawakubo K, and Taché Y. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways. Am J Physiol Gastrointest Liver Physiol 277: G555-G562, 1999.
42. Yang H, Kawakubo K, Wong H, Ohning G, Walsh J, and Taché Y. Peripheral PYY inhibits intracisternal TRH-induced gastric acid secretion by acting in the brain. Am J Physiol Gastrointest Liver Physiol 279: G575-G581, 2000.
43. Yang H, Li WP, Reeve JRJ, Rivier J, and Taché Y. PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats. Br J Pharmacol 123: 1549-1554, 1998.
44. Yang H and Taché Y. PYY in brain stem nuclei induces vagal stimulation of gastric acid secretion in rats. Am J Physiol Gastrointest Liver Physiol 268: G943-G948, 1995.
45. Yoneda M, Nakamura K, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Kono T, and Makino I. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats. Hepatology 28: 670-676, 1998.
46. Yoneda M and Taché Y. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats. Gastroenterology 102: 1568-1574, 1992.